# FDA Inspection 1283672 - UPMC Childrens Hospital Of Pittsburgh - September 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/upmc-childrens-hospital-of-pittsburgh/a9c06f50-42a8-4aa0-8aa5-4741e3282eab
Source feed: FDA_Inspections

> FDA Inspection 1283672 for UPMC Childrens Hospital Of Pittsburgh on September 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283672
- Company Name: UPMC Childrens Hospital Of Pittsburgh
- Inspection Date: 2025-09-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283672 - 2025-09-17](https://www.keypedia.com/records/fda_inspections/upmc-childrens-hospital-of-pittsburgh/0afd54e5-1f7a-4c2f-8176-491e06cb4fff)
- [FDA Inspection 1077868 - 2019-01-17](https://www.keypedia.com/records/fda_inspections/upmc-childrens-hospital-of-pittsburgh/24b0937d-85e8-42d8-b8e8-f8d9e4281b53)
- [FDA Inspection 976949 - 2016-07-18](https://www.keypedia.com/records/fda_inspections/upmc-childrens-hospital-of-pittsburgh/cf03b692-8c69-4b20-ab93-0ef074de3df4)

Company: https://www.keypedia.com/companies/upmc-childrens-hospital-of-pittsburgh/1dd1b3f7-332f-4b8b-9274-df6673c7ed96

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d